The UK charity for Waldenstrom’s macroglobulinaemia – a rare type of blood cancer
Support Line: 0300 373 8500

Factsheet: How to access zanubrutinib

March 15, 2024

We know patients are concerned about accessing zanubrutinib...

Following the decision from the National Institute for Clinical Excellence (NICE), we know patients are concerned about accessing zanubrutinib. We’ve put together this handy guide to help you access it (and what you need to ask your consultant).

Related Documents

Related conditions and symptoms of WM
Understanding Related Conditions and Symptoms of Waldenström’s Macroglobulinaemia (WM)
WMUK Impact Report 23-24
Funded by the generosity and dedication of the WM community
Newly Diagnosed Guide
2nd Edition